MetLife Investment Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-5,069
Closed -$40.7K 2565
2021
Q3
$40.7K Sell
5,069
-9,638
-66% -$77.3K ﹤0.01% 2539
2021
Q2
$167K Buy
+14,707
New +$167K ﹤0.01% 2265